Skip to main content

Radioactive Drug Research Committee


The Radioactive Drug Research Committee provides authorization, surveillance and oversight to the use of radioactive drugs in human subjects. The committee is a subcommittee of, and reports to, the Radiation Safety Committee but operates under approval of the Food and Drug Administration (FDA) according to Part 361 of Title 21 of the Code of Federal Regulations.

Meetings will be held as necessary to review and conduct committee business, with at least one meeting per calendar quarter.

A quorum of this committee, consisting of at least four members, including the Radiation Safety Officer, is necessary to conduct business.

The committe chair shall also serve as an ex officio member of the Radiation Safety Committee.

Committee Members

See the current member list.


Contact Marie-Pierre Murry, (858) 534-6821.